Joint (JYNT) Earning Neutral Media Coverage, Report Shows
Headlines about Joint (NASDAQ:JYNT) have trended neutral on Friday, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by monitoring more than 6,000 news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Joint earned a daily sentiment score of 0.25 on their scale. InfoTrie also assigned headlines about the company an news buzz score of 0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company’s share price in the next several days.
Here are some of the news articles that may have effected Joint’s analysis:
- Joint (JYNT) Receiving Neutral Press Coverage, Report Finds (americanbankingnews.com)
- Joint Corp (JYNT) Expected to Post Quarterly Sales of $8.90 Million (americanbankingnews.com)
- 2 ASCs earn The Joint Commission’s Gold Seal of Approval (beckersasc.com)
- MOH vs. JYNT: Which Stock Is the Better Value Option? (finance.yahoo.com)
- Zacks: Analysts Expect Joint Corp (JYNT) Will Announce Earnings of $0.01 Per Share (americanbankingnews.com)
A number of research firms have commented on JYNT. Zacks Investment Research lowered Joint from a “hold” rating to a “sell” rating in a research report on Wednesday, March 13th. DA Davidson upped their price target on Joint to $15.00 and gave the company a “buy” rating in a research report on Friday, March 8th. Lake Street Capital upped their price target on Joint to $20.00 and gave the company a “buy” rating in a research report on Friday, March 8th. ValuEngine raised Joint from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, February 20th. Finally, Maxim Group reaffirmed a “buy” rating and set a $18.00 price target (up previously from $11.00) on shares of Joint in a research report on Friday, March 8th. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Joint presently has an average rating of “Buy” and an average target price of $14.95.
Joint (NASDAQ:JYNT) last released its quarterly earnings results on Thursday, March 7th. The company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.01. The business had revenue of $9.07 million during the quarter, compared to analyst estimates of $8.65 million. Joint had a return on equity of 39.20% and a net margin of 0.80%. On average, equities research analysts forecast that Joint will post 0.2 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This piece of content was posted by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/joint-jynt-earning-neutral-media-coverage-report-shows/2924952.html.
Joint Company Profile
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics in the United States. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of December 31, 2018, the company operated 442, including 394 franchised clinics, and 48 corporate owned or managed clinics.
Featured Story: Benefits of owning preferred stock
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.